In addition to BRCA1 and 2, recent studies show that mutations in PALB2, ATM, CHEK2, and TP53 genes, and to a lesser extent BARD1, RAD51C and RAD51D, significantly elevate lifetime breast cancer risk14,15. This evidence concerns the gene BRCA1 and breast carcinoma.